相似文献/References:
[1]王朋,崔邦平,代文莉,等.18F-FDG PET/CT在前列腺癌中的应用进展[J].国际放射医学核医学杂志,2016,40(4):277.[doi:10.3760/cma.j.issn.1673-4114.2016.04.008]
Wang Peng,Cui Bangping,Dai Wenli,et al.Progress in the application of 18F-FDG PET/CT in prostate cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):277.[doi:10.3760/cma.j.issn.1673-4114.2016.04.008]
[2]廖光星,冷志欣,肖国有.前列腺癌骨转移影像诊断方法研究进展[J].国际放射医学核医学杂志,2016,40(6):464.[doi:10.3760/cma.j.issn.1673-4114.2016.06.012]
Liao Guangxing,Leng Zhixin,Xiao Guoyou.Progress of imaging in the diagnosis of bone metastases of prostate cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):464.[doi:10.3760/cma.j.issn.1673-4114.2016.06.012]
[3]刘辰,杨悦,张雪宁,等.MRI和1997年版Partin表对前列腺癌病理特征预测准确性的对比研究[J].国际放射医学核医学杂志,2015,39(2):124.[doi:10.3760/cma.j.issn.1673-4114.2015.02.005]
Liu Chen,Yang Yue,Zhang Xuening,et al.Accuracy of MRI and 1997 edition of Partin tables in predicting the pathological features of prostate cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(5):124.[doi:10.3760/cma.j.issn.1673-4114.2015.02.005]
[4]桂继琮,刘兴党.镭-223氯化物治疗去势抵抗性前列腺癌骨转移的研究进展[J].国际放射医学核医学杂志,2015,39(3):268.[doi:10.3760/cma.j.issn.1673-4114.2015.03.018]
Gui Jicong,Liu Xingdang.Development in the study of radium-223 chloride for treating castration-resistant prostate carcinoma with bone metastases[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(5):268.[doi:10.3760/cma.j.issn.1673-4114.2015.03.018]
[5]张晖,段清,卓娜,等.经直肠超声引导下“6+X”点法前列腺穿刺活检诊断前列腺癌的临床价值分析[J].国际放射医学核医学杂志,2015,39(4):308.[doi:10.3760/cma.j.issn.1673-4114.2015.04.008]
Zhang Hui,Duan Qing,Zhuo Na,et al.Meta-analysis of the diagnostic value of transrectal ultrasound-guided “6+X” points biopsy in prostate cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(5):308.[doi:10.3760/cma.j.issn.1673-4114.2015.04.008]
[6]张龙敏,刘爱连.前列腺癌MRI诊断技术研究进展[J].国际放射医学核医学杂志,2014,38(1):53.[doi:10.3760/cma.j.issn 1673-4114.2014.01.011]
Zhang Longmin,Liu Ailian.Advances in MRI diagnosis of prostate cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(5):53.[doi:10.3760/cma.j.issn 1673-4114.2014.01.011]
[7]刘辰,杨悦,张雪宁,等.CT/MRI图像融合在前列腺癌IMRT中的应用进展[J].国际放射医学核医学杂志,2014,38(4):247.[doi:10.3760/cma.j.issn.1673-4114.2014.04.010]
Liu Chen,Yang Yue,Zhang Xuening,et al.CT/MRI image fusion in intensity modulated radiation therapy for prostate cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(5):247.[doi:10.3760/cma.j.issn.1673-4114.2014.04.010]
[8]袁超,李卫鹏,胡永全,等.89Sr治疗乳腺癌和前列腺癌多发性骨转移的临床观察[J].国际放射医学核医学杂志,2010,34(4):220.[doi:10.3760/cma.j.issn.1673-4114.2010.04.008]
YUAN Chao,LI Wei-peng,HU Yong-quan,et al.Clinical observation of 89Sr treatment efficacy of multiple bone metastases in breast and prostate cancer patients[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(5):220.[doi:10.3760/cma.j.issn.1673-4114.2010.04.008]
[9]徐慧琴,薛杨央,赵学峰,等.18F-FDG PET-CT诊断前列腺癌复发与转移的价值[J].国际放射医学核医学杂志,2011,35(2):81.[doi:10.3760/cma.j.issn.1673-4114.2011.02.004]
XU Hui-qin,XUE Yang-yang,ZHAO Xue-feng,et al.Value of 18F-FDG PET-CT in diagnoss of prostate cancer recurrence and metastasis[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(5):81.[doi:10.3760/cma.j.issn.1673-4114.2011.02.004]
[10]邢岩,赵晋华.放射性核素标记铃蟾肽在前列腺癌诊治中的研究进展[J].国际放射医学核医学杂志,2010,34(3):158.
XING Yan,ZHAO Jin-hua.Progress of radiolabelled bombesin in diagnosis and treatment of prostate cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(5):158.
[11]徐海青,段俊,吴边.全身骨显像诊断前列腺癌骨转移与PSA水平及病理分级的相关性研究[J].国际放射医学核医学杂志,2011,35(1):34.[doi:10.3760/cma.j.issn.1673-4114.2011.01.010]
XU Hai-qing,DUAN Jun,WU Bian.Study of relationship between the bone imaging, level of PSA and pathology grade in diagnosis of prostate carcinoma bone metastasis[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(5):34.[doi:10.3760/cma.j.issn.1673-4114.2011.01.010]
[12]钟兴祥,刘思平,郑吉祥,等.血清FPSA/TPSA值在前列腺癌鉴别诊断中的价值[J].国际放射医学核医学杂志,2010,34(3):161.
ZHONG Xing-xiang,LIU Si-ping,ZHENG Ji-xiang,et al.The clinical valuation of serum FPSA/FPSA in the diagnosis of prostate cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(5):161.
[13]黄诚刚,陈小艳,马春清,等.血清FPSA/TPSA及性腺激素测定结合核素骨显像在前列腺癌诊断、复发和转移中的临床价值[J].国际放射医学核医学杂志,2010,34(6):337.[doi:10.3760/cma.j.issn.1673-4114,2010.06.005]
HUANG Cheng-gang,CHEN Xiao-yan,MA Chun-qing,et al.Evaluation of serum FPSA/TPSA and hormone determination combinded with nuclide bone imaging in diagnosis of prostate carcinoma and its recidivation and metastasis[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(5):337.[doi:10.3760/cma.j.issn.1673-4114,2010.06.005]